U.S. pharma big copyright scrapped two experimental weight loss products last yr—a at the time-daily tablet, lotiglipron, as a result of elevated liver enzymes and a 2 times-everyday pill, danuglipron, because of robust Unintended effects—but CEO Albert Bourla has mentioned the company is determined to “Perform and earn” in the weight probl… Read More